Latest filing published 18 Aug 2026 for BIO-TECHNE Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Amy E. Herr appears in our data through filings on BIO-TECHNE Corp shares, published by SEC (Form 4). Over a trading history stretching from 3 February 2025 to 15 August 2026, the count stands at 9 filings.
Every open-market trade on record is a sale: 1 sale worth €99k. The rest of the record consists of 3 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 18 August 2026 came the latest disclosure, an option exercise in BIO-TECHNE Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations